| 摘要 |
The present invention relates to an eprosartan solid dispersant with improved bioavailability, a method for manufacturing the same, and a use thereof and, more specifically, to an eprosartan solid dispersant comprising amorphous eprosartan by including eprosartan, a hydrophilic polymer, and a surfactant via spray drying, a method for manufacturing the same, and a use thereof. The eprosartan solid dispersant is manufactured for eprosartan to have an amorphous crystal structure. The eprosartan solid dispersant can be used as a therapeutic agent for preventing or treating hypertension, congestive heart failure, and renal failure by improving solubility and dissolution rate of eprosartan, thereby improving bioavailability of eprosartan. [Reference numerals] (AA) Eprosartan; (BB) Example 1; (CC) Example 2; (DD) Example 3 |
